About the Authors

Koen B. Pouwels

k.b.pouwels@gmail.com

Affiliations Unit of PharmacoEpidemiology & PharmacoEconomics, Department of Pharmacy, University of Groningen, Groningen, The Netherlands, Modelling & Economics Unit, Centre for Infectious Disease Surveillance & Control, Public Health England, London, United Kingdom

Sefika E. Bozdemir

Affiliation Division of Pediatric Infectious Diseases, Uludağ University Faculty of Medicine, Bursa, Turkey

Selen Yegenoglu

Affiliation Department of Pharmacy Management, Hacettepe University Faculty of Pharmacy, Ankara, Turkey

Solmaz Celebi

Affiliation Division of Pediatric Infectious Diseases, Uludağ University Faculty of Medicine, Bursa, Turkey

E. David McIntosh

Affiliation Department of Medicine, Imperial College London, London, United Kingdom

Serhat Unal

Affiliation Department of Infectious Diseases and Clinical Microbiology, Hacettepe University Faculty of Medicine, Ankara, Turkey

Maarten J. Postma

Affiliations Unit of PharmacoEpidemiology & PharmacoEconomics, Department of Pharmacy, University of Groningen, Groningen, The Netherlands, Institute of Science in Healthy Aging & healthcaRE (SHARE), University Medical Center Groningen (UMCG), Groningen, The Netherlands, Department of Epidemiology, UMCG, University of Groningen, Groningen, The Netherlands

Mustafa Hacimustafaoglu

Affiliation Division of Pediatric Infectious Diseases, Uludağ University Faculty of Medicine, Bursa, Turkey

Competing Interests

ED McIntosh is a former employee of Novartis Vaccines, which was developing an RSV vaccine. Since the study, ED McIntosh has become an employee of Takeda Vaccines. Takeda Vaccines is not developing a RSV vaccine. MJ Postma received grants and honoraria from GSK, Pfizer, Astellas, Astra Zeneca, Sanofi, SPMSD, Vertex, SHIRE, Amgen, Novartis, Novavax, and Intercept, owns 3% of shares of Ingress Health, and is advisor to Mihajlovic Health Economics and AscAcademics. The authors declare that they have no conflict of interest in relation to this work. There are no patents, products in development, or marketed products to declare. This does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.

Author Contributions

Conceptualization: KBP SEB SY SC EDM SU MJP MH. Formal analysis: KBP. Methodology: KBP EDM MJP. Resources: SEB SY SC SU MH. Writing – original draft: KBP. Writing – review & editing: KBP SEB SY SC EDM SU MJP MH.